Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Role of DJ-1 in Modulating Glycative Stress in Heart Failure.

Shimizu Y, Nicholson CK, Polavarapu R, Pantner Y, Husain A, Naqvi N, Chin LS, Li L, Calvert JW.

J Am Heart Assoc. 2020 Feb 18;9(4):e014691. doi: 10.1161/JAHA.119.014691. Epub 2020 Feb 13.

2.

Development and evaluation of LAMP-coupled lateral flow device for the detection of MAP in livestock at point of care resource-limited areas.

Punati RD, Mallepaddi PC, Poonati R, Maity SN, Sohal JS, Polavarapu KKB, Polavarapu R.

Braz J Microbiol. 2019 Oct;50(4):1105-1114. doi: 10.1007/s42770-019-00116-z. Epub 2019 Sep 20.

PMID:
31541428
3.

Development of the First Low Nanomolar Liver Receptor Homolog-1 Agonist through Structure-guided Design.

Mays SG, Flynn AR, Cornelison JL, Okafor CD, Wang H, Wang G, Huang X, Donaldson HN, Millings EJ, Polavarapu R, Moore DD, Calvert JW, Jui NT, Ortlund EA.

J Med Chem. 2019 Dec 26;62(24):11022-11034. doi: 10.1021/acs.jmedchem.9b00753. Epub 2019 Sep 6.

PMID:
31419141
4.
5.

Rayleigh-Taylor-instability experiments with elastic-plastic materials.

Polavarapu R, Roach P, Banerjee A.

Phys Rev E. 2019 May;99(5-1):053104. doi: 10.1103/PhysRevE.99.053104.

PMID:
31212421
6.

Selecting better diagnostic kits for diagnosis of malarial parasites at point of care.

Mallepaddi PC, Maity SN, Poonati R, Pyadala N, Polavarapu R, Mangamuri UK, Poda S.

3 Biotech. 2019 Jan;9(1):36. doi: 10.1007/s13205-018-1566-7. Epub 2019 Jan 5.

7.

MedPServer: A database for identification of therapeutic targets and novel leads pertaining to natural products.

Potshangbam AM, Polavarapu R, Rathore RS, Naresh D, Prabhu NP, Potshangbam N, Kumar P, Vindal V.

Chem Biol Drug Des. 2019 Apr;93(4):438-446. doi: 10.1111/cbdd.13430. Epub 2018 Nov 28.

PMID:
30381914
8.

Impact of Lymphangiogenesis on Cardiac Remodeling After Ischemia and Reperfusion Injury.

Shimizu Y, Polavarapu R, Eskla KL, Pantner Y, Nicholson CK, Ishii M, Brunnhoelzl D, Mauria R, Husain A, Naqvi N, Murohara T, Calvert JW.

J Am Heart Assoc. 2018 Oct 2;7(19):e009565. doi: 10.1161/JAHA.118.009565.

9.

Development of Loop-Mediated Isothermal Amplification-Based Lateral Flow Device Method for the Detection of Malaria.

Mallepaddi PC, Lai MY, Podha S, Ooi CH, Liew JW, Polavarapu R, Lau YL.

Am J Trop Med Hyg. 2018 Sep;99(3):704-708. doi: 10.4269/ajtmh.18-0177. Epub 2018 Jun 21.

10.

CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis.

Guo L, Akahori H, Harari E, Smith SL, Polavarapu R, Karmali V, Otsuka F, Gannon RL, Braumann RE, Dickinson MH, Gupta A, Jenkins AL, Lipinski MJ, Kim J, Chhour P, de Vries PS, Jinnouchi H, Kutys R, Mori H, Kutyna MD, Torii S, Sakamoto A, Choi CU, Cheng Q, Grove ML, Sawan MA, Zhang Y, Cao Y, Kolodgie FD, Cormode DP, Arking DE, Boerwinkle E, Morrison AC, Erdmann J, Sotoodehnia N, Virmani R, Finn AV.

J Clin Invest. 2018 Mar 1;128(3):1106-1124. doi: 10.1172/JCI93025. Epub 2018 Feb 19.

11.

Hydrogen sulfide regulates cardiac mitochondrial biogenesis via the activation of AMPK.

Shimizu Y, Polavarapu R, Eskla KL, Nicholson CK, Koczor CA, Wang R, Lewis W, Shiva S, Lefer DJ, Calvert JW.

J Mol Cell Cardiol. 2018 Mar;116:29-40. doi: 10.1016/j.yjmcc.2018.01.011. Epub 2018 Feb 3.

12.

Balloon Angioplasty for Intracranial Atherosclerotic Disease: A Multicenter Study.

Karanam LSP, Sharma M, Alurkar A, Baddam SR, Pamidimukkala V, Polavarapu R.

J Vasc Interv Neurol. 2017 Jun;9(4):29-34.

13.

Local Intrasinus Thrombolysis for Cerebral Venous Sinus Thrombosis.

Karanam LS, Baddam SR, Pamidimukkala V, Vemuri R, Byrapaneni S, Polavarapu R.

J Vasc Interv Neurol. 2016 Oct;9(2):49-54.

14.

One-year outcomes of a BioMime™ Sirolimus-Eluting Coronary Stent System with a biodegradable polymer in all-comers coronary artery disease patients: The meriT-3 study.

Jain RK, Chakravarthi P, Shetty R, Ramchandra P, Polavarapu RS, Wander GS, Mohan B, Banker DN, Dharmadhikari A, Bansal SS, Jain N, Solanki D, Dhakaan J, Sharma VP, Mohanan PP, Ashokan PK, Manjunath BV, Hiregoudar N, Patil C, Balakrishnan N.

Indian Heart J. 2016 Sep - Oct;68(5):599-603. doi: 10.1016/j.ihj.2016.09.007. Epub 2016 Sep 28.

15.

Clinical Outcomes from Unselected "Real-World" Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent.

Polavarapu A, Polavarapu RS, Prajapati J, Thakkar K, Raheem A, Mayall T, Thakkar A.

Scientifica (Cairo). 2015;2015:613089. doi: 10.1155/2015/613089. Epub 2015 Oct 22.

16.

Favorable Outcomes after Implantation of Biodegradable Polymer Coated Sirolimus-Eluting Stents in Diabetic Population: Results from INDOLIMUS-G Diabetic Registry.

Polavarapu A, Polavarapu RS, Prajapati J, Raheem A, Thakkar K, Kothari S, Thakkar A.

Int J Vasc Med. 2015;2015:265670. doi: 10.1155/2015/265670. Epub 2015 Sep 2.

17.

CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injury.

Akahori H, Karmali V, Polavarapu R, Lyle AN, Weiss D, Shin E, Husain A, Naqvi N, Van Dam R, Habib A, Choi CU, King AL, Pachura K, Taylor WR, Lefer DJ, Finn AV.

Nat Commun. 2015 Aug 5;6:7792. doi: 10.1038/ncomms8792.

18.

Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques.

Habib A, Polavarapu R, Karmali V, Guo L, Van Dam R, Cheng Q, Akahori H, Saeed O, Nakano M, Pachura K, Hong CC, Shin E, Kolodgie F, Virmani R, Finn AV.

Atherosclerosis. 2015 Aug;241(2):692-700. doi: 10.1016/j.atherosclerosis.2015.06.025. Epub 2015 Jun 19.

19.

ClosIndb: A resource for computationally derived information from clostridial genomes.

Polavarapu R, Meetei PA, Midha M, Bharne D, Vindal V.

Infect Genet Evol. 2015 Jul;33:127-30. doi: 10.1016/j.meegid.2015.04.020. Epub 2015 Apr 23.

PMID:
25913159
20.

Everolimus-eluting stents improve vascular response in a diabetic animal model.

Habib A, Karmali V, John MC, Polavarapu R, Nakazawa G, Pachura K, Davis T, Kolodgie FD, Virmani R, Finn AV.

Circ Cardiovasc Interv. 2014 Aug;7(4):526-32. doi: 10.1161/CIRCINTERVENTIONS.113.001023. Epub 2014 Jun 10.

21.

Sirolimus-FKBP12.6 impairs endothelial barrier function through protein kinase C-α activation and disruption of the p120-vascular endothelial cadherin interaction.

Habib A, Karmali V, Polavarapu R, Akahori H, Cheng Q, Pachura K, Kolodgie FD, Finn AV.

Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2425-31. doi: 10.1161/ATVBAHA.113.301659. Epub 2013 Jul 25.

22.

Metformin impairs endothelialization after placement of newer generation drug eluting stents.

Habib A, Karmali V, Polavarapu R, Akahori H, Pachura K, Finn AV.

Atherosclerosis. 2013 Aug;229(2):385-7. doi: 10.1016/j.atherosclerosis.2013.06.001. Epub 2013 Jun 14.

23.

Simple, rapid, inexpensive platform for the diagnosis of malaria by loop mediated isothermal amplification (LAMP).

Surabattula R, Vejandla MP, Mallepaddi PC, Faulstich K, Polavarapu R.

Exp Parasitol. 2013 Jul;134(3):333-40. doi: 10.1016/j.exppara.2013.03.031. Epub 2013 Apr 4.

24.

Metformin impairs vascular endothelial recovery after stent placement in the setting of locally eluted mammalian target of rapamycin inhibitors via S6 kinase-dependent inhibition of cell proliferation.

Habib A, Karmali V, Polavarapu R, Akahori H, Nakano M, Yazdani S, Otsuka F, Pachura K, Davis T, Narula J, Kolodgie FD, Virmani R, Finn AV.

J Am Coll Cardiol. 2013 Mar 5;61(9):971-80. doi: 10.1016/j.jacc.2012.12.018.

25.

OrFin: A web tool for detection of putative orthologs.

Midha M, Polavarapu R, Meetei PA, Krishnan H, Mohareer K, Vindal V.

Bioinformation. 2012;8(15):738-9. doi: 10.6026/97320630008738. Epub 2012 Aug 3.

26.

Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques.

Finn AV, Nakano M, Polavarapu R, Karmali V, Saeed O, Zhao X, Yazdani S, Otsuka F, Davis T, Habib A, Narula J, Kolodgie FD, Virmani R.

J Am Coll Cardiol. 2012 Jan 10;59(2):166-77. doi: 10.1016/j.jacc.2011.10.852. Epub 2011 Dec 9.

27.

Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis.

Saeed O, Otsuka F, Polavarapu R, Karmali V, Weiss D, Davis T, Rostad B, Pachura K, Adams L, Elliott J, Taylor WR, Narula J, Kolodgie F, Virmani R, Hong CC, Finn AV.

Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):299-307. doi: 10.1161/ATVBAHA.111.240101. Epub 2011 Nov 17.

28.

Differential healing after sirolimus, paclitaxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor gamma agonists: requirement for mTOR/Akt2 in PPARgamma activation.

Finn AV, John M, Nakazawa G, Polavarapu R, Karmali V, Xu X, Cheng Q, Davis T, Raghunathan C, Acampado E, Ezell T, Lajoie S, Eppihimer M, Kolodgie FD, Virmani R, Gold HK.

Circ Res. 2009 Nov 6;105(10):1003-12. doi: 10.1161/CIRCRESAHA.109.200519. Epub 2009 Sep 24.

29.

Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain.

An J, Zhang C, Polavarapu R, Zhang X, Zhang X, Yepes M.

Blood. 2008 Oct 1;112(7):2787-94. doi: 10.1182/blood-2008-02-141630. Epub 2008 Jul 15.

30.

Regulated intramembrane proteolysis of the low-density lipoprotein receptor-related protein mediates ischemic cell death.

Polavarapu R, An J, Zhang C, Yepes M.

Am J Pathol. 2008 May;172(5):1355-62. doi: 10.2353/ajpath.2008.070975. Epub 2008 Apr 10.

31.

Increased severity of alcoholic liver injury in female verses male rats: a microarray analysis.

Sharma MR, Polavarapu R, Roseman D, Patel V, Eaton E, Kishor PB, Nanji AA.

Exp Mol Pathol. 2008 Feb;84(1):46-58. Epub 2007 Oct 22.

PMID:
18062962
32.
33.

Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit.

Polavarapu R, Gongora MC, Yi H, Ranganthan S, Lawrence DA, Strickland D, Yepes M.

Blood. 2007 Apr 15;109(8):3270-8. Epub 2006 Dec 14.

34.

Transcriptional networks in a rat model for nonalcoholic fatty liver disease: a microarray analysis.

Sharma MR, Polavarapu R, Roseman D, Patel V, Eaton E, Kishor PB, Nanji AA.

Exp Mol Pathol. 2006 Dec;81(3):202-10. Epub 2006 Sep 1.

PMID:
16949573
35.

TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.

Zhang X, Winkles JA, Gongora MC, Polavarapu R, Michaelson JS, Hahm K, Burkly L, Friedman M, Li XJ, Yepes M.

J Cereb Blood Flow Metab. 2007 Mar;27(3):534-44. Epub 2006 Jul 12.

PMID:
16835630
37.

Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion.

Lu XC, Williams AJ, Yao C, Berti R, Hartings JA, Whipple R, Vahey MT, Polavarapu RG, Woller KL, Tortella FC, Dave JR.

J Neurosci Res. 2004 Sep 15;77(6):843-57.

PMID:
15334602
38.

Class I alcohol dehydrogenase is highly expressed in normal human mammary epithelium but not in invasive breast cancer: implications for breast carcinogenesis.

Triano EA, Slusher LB, Atkins TA, Beneski JT, Gestl SA, Zolfaghari R, Polavarapu R, Frauenhoffer E, Weisz J.

Cancer Res. 2003 Jun 15;63(12):3092-100.

39.

Arginine reverses ethanol-induced inflammatory and fibrotic changes in liver despite continued ethanol administration.

Nanji AA, Jokelainen K, Lau GK, Rahemtulla A, Tipoe GL, Polavarapu R, Lalani EN.

J Pharmacol Exp Ther. 2001 Dec;299(3):832-9.

PMID:
11714866
40.

Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology.

Akalin E, Hendrix RC, Polavarapu RG, Pearson TC, Neylan JF, Larsen CP, Lakkis FG.

Transplantation. 2001 Sep 15;72(5):948-53.

PMID:
11571464
41.

Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1.

Arnold RS, Shi J, Murad E, Whalen AM, Sun CQ, Polavarapu R, Parthasarathy S, Petros JA, Lambeth JD.

Proc Natl Acad Sci U S A. 2001 May 8;98(10):5550-5. Epub 2001 May 1.

42.

Expression of brain Gi protein in the aging F344 rat following exposure to corticosterone.

Maines LW, Polavarapu R, Lakoski JM.

Int J Dev Neurosci. 1998 Aug;16(5):341-6.

PMID:
9829170
43.

Chromosomal localization and characterization of the stannin (Snn) gene.

Dejneka NS, Polavarapu R, Deng X, Martin-DeLeon PA, Billingsley ML.

Mamm Genome. 1998 Jul;9(7):556-64.

PMID:
9657854
44.
45.

Localization and characterization of stannin: relationship to cellular sensitivity to organotin compounds.

Dejneka NS, Patanow CM, Polavarapu R, Toggas SM, Krady JK, Billingsley ML.

Neurochem Int. 1997 Dec;31(6):801-15.

PMID:
9413842
46.

Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats.

Wrzos HF, Cruz A, Polavarapu R, Shearer D, Ouyang A.

Dig Dis Sci. 1997 Oct;42(10):2106-10.

PMID:
9365143
47.

Induction of apoptosis by organotin compounds in vitro: neuronal protection with antisense oligonucleotides directed against stannin.

Thompson TA, Lewis JM, Dejneka NS, Severs WB, Polavarapu R, Billingsley ML.

J Pharmacol Exp Ther. 1996 Mar;276(3):1201-16.

PMID:
8786553
48.

Tau phosphorylation in brain slices: pharmacological evidence for convergent effects of protein phosphatases on tau and mitogen-activated protein kinase.

Garver TD, Oyler GA, Harris KA, Polavarapu R, Damuni Z, Lehman RA, Billingsley ML.

Mol Pharmacol. 1995 Apr;47(4):745-56.

PMID:
7723735

Supplemental Content

Loading ...
Support Center